{"id":185246,"date":"2026-08-19T19:51:20","date_gmt":"2026-08-19T19:51:20","guid":{"rendered":"https:\/\/www.europesays.com\/cz\/185246\/"},"modified":"2026-08-19T19:51:20","modified_gmt":"2026-08-19T19:51:20","slug":"testy-naznacily-uspesnou-lecbu-rakoviny-akcie-moderny-zdvojnasobily-hodnotu","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/cz\/185246\/","title":{"rendered":"Testy nazna\u010dily \u00fasp\u011b\u0161nou l\u00e9\u010dbu rakoviny, akcie Moderny zdvojn\u00e1sobily hodnotu"},"content":{"rendered":"

Akcie spole\u010dnosti Moderna ve st\u0159edu na burze v\u00edce ne\u017e zdvojn\u00e1sobily hodnotu. Personalizovan\u00e1 terapie proti rakovin\u011b od t\u00e9to americk\u00e9 biotechnologick\u00e9 spole\u010dnosti vyvinut\u00e1 ve spolupr\u00e1ci s\u00a0americkou farmaceutickou firmou Merck toti\u017e v\u00a0pokro\u010dil\u00e9 f\u00e1zi klinick\u00e9ho testov\u00e1n\u00ed v\u00a0kombinaci s\u00a0p\u0159\u00edpravkem Keytruda sn\u00ed\u017eila riziko n\u00e1vratu a\u00a0\u0161\u00ed\u0159en\u00ed melanomu. Firmy to uvedly v\u00a0dne\u0161n\u00ed tiskov\u00e9 zpr\u00e1v\u011b<\/a>.<\/p>\n

Pozitivn\u00ed v\u00fdsledek test\u016f vedl k\u00a0prudk\u00e9mu r\u016fstu ceny akci\u00ed Moderny. Ty kr\u00e1tce po zah\u00e1jen\u00ed dne\u0161n\u00edho obchodov\u00e1n\u00ed v\u00a0New Yorku v\u00fdrazn\u011b vzrostly a\u00a0zhruba po hodin\u011b obchodov\u00e1n\u00ed p\u0159id\u00e1valy 150\u00a0procent p\u0159ibli\u017en\u011b na 158\u00a0USD za kus a\u00a0d\u00e1le se dr\u017eely v\u00a0rozmez\u00ed mezi 140\u00a0a\u00a0160\u00a0dolary na akcii. Je\u0161t\u011b po\u010d\u00e1tkem t\u00fddne se p\u0159itom obchodovaly s\u00a0cenou m\u00edrn\u011b nad \u0161edes\u00e1t dolar\u016f.<\/p>\n

Akcie Mercku ve stejnou dobu vykazovaly r\u016fst o\u00a0v\u00edce ne\u017e deset procent nad 149\u00a0dolar\u016f a\u00a0i ony z\u016fst\u00e1valy v\u00a0prvn\u00edch hodin\u00e1ch na zv\u00fd\u0161en\u00e9 \u00farovni.<\/p>\n

<\/a><\/p>\n

P\u0159edb\u011b\u017en\u00e9 v\u00fdsledky studie uk\u00e1zaly, \u017ee l\u00e9\u010dba p\u0159\u00edpravkem Intismeran splnila jak prim\u00e1rn\u00ed c\u00edl, j\u00edm\u017e bylo sn\u00ed\u017een\u00ed n\u00e1vratu rakoviny, tak i\u00a0sekund\u00e1rn\u00ed c\u00edl, kter\u00fdm bylo zabr\u00e1nit \u0161\u00ed\u0159en\u00ed n\u00e1dor\u016f do jin\u00fdch \u010d\u00e1st\u00ed t\u011bla, a\u00a0to ve srovn\u00e1n\u00ed s\u00a0l\u00e9\u010dbou samotn\u00fdm p\u0159\u00edpravkem Keytruda.<\/p>\n

Jde o\u00a0prvn\u00ed pozitivn\u00ed v\u00fdsledek klinick\u00e9 studie v\u00a0pokro\u010dil\u00e9 f\u00e1zi u\u00a0vakc\u00edny mRNA proti rakovin\u011b a\u00a0o prvn\u00ed takovou studii, kter\u00e1 prok\u00e1zala, \u017ee p\u0159id\u00e1n\u00ed t\u00e9to l\u00e9\u010dby k\u00a0p\u0159\u00edpravku Keytruda u\u00a0pacient\u016f, u\u00a0nich\u017e byl melanom chirurgicky odstran\u011bn, bylo \u00fa\u010dinn\u011bj\u0161\u00ed ne\u017e l\u00e9\u010dba samotn\u00fdm p\u0159\u00edpravkem.<\/p>\n

Zpr\u00e1va pravd\u011bpodobn\u011b uklidn\u00ed obavy investor\u016f ohledn\u011b dlouhodob\u00e9ho r\u016fstu obou spole\u010dnost\u00ed, uvedla agentura Reuters. Moderna hled\u00e1 mo\u017enosti r\u016fstu po \u00fasp\u011bchu vakc\u00edny Spikevax proti nemoci covid-19, zat\u00edmco Merck se p\u0159ipravuje na bl\u00ed\u017e\u00edc\u00ed se vypr\u0161en\u00ed patentu na sv\u016fj nej\u00fasp\u011b\u0161n\u011bj\u0161\u00ed p\u0159\u00edpravek Keytruda ve druh\u00e9 polovin\u011b tohoto desetilet\u00ed.<\/p>\n

P\u016fvodn\u00ed n\u00e1zev Moderny zn\u011bl ModeRNA Therapeutics a\u00a0jej\u00edm c\u00edlem bylo od za\u010d\u00e1tku vyu\u017eit\u00ed technologie mRNA k\u00a0v\u00fdvoji vakc\u00edn proti \u0161irok\u00e9mu spektru nemoc\u00ed. Firma testuje nap\u0159\u00edklad vakc\u00edny mRNA proti HIV nebo ch\u0159ipce.<\/p>\n

Aktualizovali jsme v\u00fdvoj ceny akci\u00ed.<\/p>\n

<\/a><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Akcie spole\u010dnosti Moderna ve st\u0159edu na burze v\u00edce ne\u017e zdvojn\u00e1sobily hodnotu. Personalizovan\u00e1 terapie proti rakovin\u011b od t\u00e9to americk\u00e9…\n","protected":false},"author":2,"featured_media":185247,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[12],"tags":[412,67,68,19608,2811,11509],"class_list":["post-185246","post","type-post","status-publish","format-standard","has-post-thumbnail","category-byznys","tag-akcie","tag-business","tag-byznys","tag-moderna","tag-rakovina","tag-vakcina"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@cz\/117123919777498793","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/185246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/comments?post=185246"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/185246\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media\/185247"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media?parent=185246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/categories?post=185246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/tags?post=185246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}